Paradigm Biopharmaceuticals Limited (PBIGF)

USD 0.13

(-62.83%)

Long Term Debt Summary of Paradigm Biopharmaceuticals Limited

  • Paradigm Biopharmaceuticals Limited's latest annual long term debt in 2024 was 117.48 Thousand AUD , down 0.0% from previous year.
  • Paradigm Biopharmaceuticals Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Paradigm Biopharmaceuticals Limited reported annual long term debt of 236.69 Thousand AUD in 2023, down -49.52% from previous year.
  • Paradigm Biopharmaceuticals Limited reported annual long term debt of 468.91 Thousand AUD in 2022, down -24.03% from previous year.
  • Paradigm Biopharmaceuticals Limited reported quarterly long term debt of 117.48 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
  • Paradigm Biopharmaceuticals Limited reported quarterly long term debt of 177.02 Thousand AUD for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Paradigm Biopharmaceuticals Limited (2024 - 2014)

Historical Annual Long Term Debt of Paradigm Biopharmaceuticals Limited (2024 - 2014)

Year Long Term Debt Long Term Debt Growth
2024 117.48 Thousand AUD 0.0%
2023 236.69 Thousand AUD -49.52%
2022 468.91 Thousand AUD -24.03%
2021 617.22 Thousand AUD -17.59%
2020 748.95 Thousand AUD 0.0%
2019 - AUD 0.0%
2018 - AUD 0.0%
2017 - AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%

Peer Long Term Debt Comparison of Paradigm Biopharmaceuticals Limited

Name Long Term Debt Long Term Debt Difference
Capstone Therapeutics Corp. 8.26 Million USD 98.578%
Skye Bioscience, Inc. 171.23 Thousand USD 31.386%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 93.307%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -46.86%
Adynxx, Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 55.771%
CSL Limited 11.23 Billion USD 99.999%
Evofem Biosciences, Inc. 8000.00 USD -1368.6%
Arch Therapeutics, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 21.473%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.422%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.438%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -100.348%
Mesoblast Limited 100.29 Million USD 99.883%
Marizyme, Inc. 667.12 Thousand USD 82.389%
Genus plc 228.2 Million USD 99.949%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.929%
Therapeutic Solutions International, Inc. 5512.00 USD -2031.495%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 94.684%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 91.626%
IMV Inc. 27.39 Million USD 99.571%
AXIM Biotechnologies, Inc. 5.42 Million USD 97.835%
MultiCell Technologies, Inc. 36.43 USD -322403.431%
ONE Bio Corp. 592.19 Thousand USD 80.161%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.789%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 94.722%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 90.435%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 78.815%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -364.398%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 93.811%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 63.513%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD 21.675%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 28.45%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 99.235%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -2536.625%
Genscript Biotech Corporation 287.12 Million USD 99.959%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 6.979%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 48.76%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 48.85%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -10942.105%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 21.473%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 16.675%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 98.498%
SYBLEU INC 300 Thousand USD 60.837%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 68.165%
International Stem Cell Corporation 445 Thousand USD 73.598%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 98.558%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 74.291%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 89.88%
PureTech Health plc 18.25 Million USD 99.356%
Coeptis Therapeutics, Inc. 150 Thousand USD 21.675%
IXICO plc 275 Thousand USD 57.277%
IntelGenx Technologies Corp. 11.83 Million USD 99.008%
Gelesis Holdings, Inc. 26.3 Million USD 99.553%
CSL Limited 11.23 Billion USD 99.999%
Cellectis S.A. 36.21 Million USD 99.676%